title: Why is primary prophylaxis underutilized in the United States?
abstract: A recent article published in Haemophilia reports the results of a survey of treatment center practices in the United States, and specifically the use of prophylaxis as treatment regimen. This article discusses the issues that may contribute to utilization of prophylactic regimens and issues to consider when determining treatment programs for pediatric patients.
authors.affiliation: Indiana Hemophilia and Thrombosis Center, Indianapolis, IN 46260, USA. ashapiro@ihtc.org
authors.forename: A D
authors.initials: AD
authors.lastname: Shapiro
mesh_terms: D002405:Catheterization, Central Venous; D002408:Catheters, Indwelling; D004363:Drug Utilization; D005169:Factor VIII / Q000627:therapeutic use; D006467:Hemophilia A / Q000517:prevention & control*; D006801:Humans; D014481:United States
chemical_list: D005169:Factor VIII